Yahoo Web Search

Search results

    • Is Invitae in Danger of Running Out of Money?

      Is Invitae in Danger of Running Out of Money?

      Motley Fool· 1 year ago

      Invitae (NYSE: NVTA) is a genetic testing company that's in its early growth stages, so shareholders should expect to take on some risk with a stock like...

    • Is It Too Late to Buy Invitae Stock?

      Is It Too Late to Buy Invitae Stock?

      Motley Fool· 1 year ago

      Invitae (NYSE: NVTA) is a promising business specializing in genetic testing, which could be the wave of the future in healthcare. Genetic tests can...

    • Is Invitae Stock a Buy Now?

      Is Invitae Stock a Buy Now?

      Motley Fool· 7 months ago

      Invitae (NYSE: NVTA) recently announced news that made its shares pop. The genetic testing company won a regulatory nod for a first-of-its-kind test for...

    • Why Invitae Stock Plummeted by 15% Today

      Why Invitae Stock Plummeted by 15% Today

      Motley Fool· 2 years ago

      Genetic medical testing specialist Invitae (NYSE: NVTA) didn't pass the investment test for one researcher late on Thursday. After market hours on...

    • Invitae Stock: Bull vs. Bear

      Invitae Stock: Bull vs. Bear

      Motley Fool· 1 year ago

      Down nearly 85% in 2022. That's the situation for Invitae (NYSE: NVTA) stock. There's no way to spin that as positive news. However, this steep sell-off...